IBIO logo

IBIO
iBio Inc

92,937
Mkt Cap
$68.4M
Volume
321,089.00
52W High
$3.82
52W Low
$0.5562
PE Ratio
-1.97
IBIO Fundamentals
Price
$1.98
Prev Close
$1.95
Open
$1.87
50D MA
$2.31
Beta
1.41
Avg. Volume
1.12M
EPS (Annual)
-$1.75
P/B
1.05
Rev/Employee
$20,000.00
$2.94
Loading...
Loading...
News
all
press releases
iBio (NASDAQ:IBIO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded iBio from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Insider Buying: iBio (NASDAQ:IBIO) CFO Buys 24,835 Shares of Stock
iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of $2.02 per...
MarketBeat·11d ago
News Placeholder
Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock
iBio, Inc. (NASDAQ:IBIO - Get Free Report) insider Martin Brenner purchased 12,336 shares of the stock in a transaction dated Thursday, March 19th. The stock was purchased at an average cost of $2.02...
MarketBeat·12d ago
News Placeholder
iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares
iBio, Inc. (NASDAQ:IBIO - Get Free Report) CFO Felipe Duran bought 24,835 shares of the company's stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of...
MarketBeat·12d ago
News Placeholder
iBio (NASDAQ:IBIO) Cut to Sell at Wall Street Zen
Wall Street Zen lowered iBio from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·14d ago
News Placeholder
iBio Touts Bispecific Antibody Strategy for PH-HFpEF, Eyes Development Candidate in Q3
Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific antibody program that the company believes could become a next-generation therapy...
MarketBeat·15d ago
News Placeholder
iBio (NASDAQ:IBIO) Given Buy Rating at Chardan Capital
Chardan Capital reaffirmed a "buy" rating and issued a $5.00 price target on shares of iBio in a research note on Wednesday...
MarketBeat·17d ago
News Placeholder
iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of "Buy" by Analysts
Shares of iBio, Inc. (NASDAQ:IBIO - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are covering the company, MarketBeat.com reports. One analyst has...
MarketBeat·22d ago
News Placeholder
iBio (NYSE:IBIO) Now Covered by Analysts at JonesTrading
JonesTrading started coverage on shares of iBio in a report on Tuesday. They set a "buy" rating and a $7.00 price target for the company...
MarketBeat·1mo ago
News Placeholder
iBio (NASDAQ:IBIO) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded iBio from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
<
1
2
...
>

Latest IBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.